A Memphis-based health system agreed to a $7.25 million settlement—without admitting wrongdoing—of federal allegations that it paid kickbacks funded, in [...] …
Year: 2024
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...] …
The Biden administration will not appeal a high-profile November federal court ruling to prohibit enforcement of a 340B patient definition [...] …
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...] …
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
Among the many tumultuous developments affecting the 340B discount drug program in 2023, the most popular news articles in 340B [...] …
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-logo-final.png)
SPONSORED CONTENT
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-sidearrow-logo-final.png)
TIP: Maximize the effectiveness of your 340B program through consistent internal audits, ensuring both compliance and enhanced savings.
Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...] …
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...] …
×
*Sign up for news summaries and alerts from 340B Report